Anaphylactic shock (2nd revision). Clinical guidelines of Russian Association of Allergists and Clinical Immunologists and the All-Russian Public Organization “Federation of Anesthesiologists and Reanimatologists”
ISSN (print) 1726-9806     ISSN (online) 1818-474X
#2-2024
PDF_2024-2_7-20 (Russian)
HTML_2024-4_7-20_S (Russian)

Keywords

anaphylactic shock
epinephrine
anaphylaxis
intensive care
guideline

How to Cite

1.
Ilyina N.I., Zabolotskikh I.B., Astafieva N.G., Bayalieva A.Z., Kulikov A.V., Latysheva T.V., Lebedinskii K.M., Musaeva T.S., Myasnikova T.N., Pampura A.N., Fassakhov R.S., Shifman E.M. Anaphylactic shock (2nd revision). Clinical guidelines of Russian Association of Allergists and Clinical Immunologists and the All-Russian Public Organization “Federation of Anesthesiologists and Reanimatologists.” Annals of Critical Care. 2024;(2):7-20. doi:10.21320/1818-474X-2024-2-7-20

Statistic

Abstract Views: 3232
PDF_2024-2_7-20 (Russian) Downloads: 2493
HTML_2024-4_7-20_S (Russian) Downloads: 184
Statistic from 01.07.2024

Language

English Русский

Social Networks

Abstract

Anaphylaxis is a severe life-threatening emergency that requires prompt recognition, prompt respond and of lifesaving therapy. Therefore, anaphylaxis can develop both in a medical institution and outside it (outpatient), and physicians of any specialties should be ready to treat this condition. In this regard, clinical guidelines for anaphylaxis have been developed in Russia. Previous version of recommendations were approved by the Russian Association of Allergologists and Clinical Immunologists and the Federation of Anesthesiologists and Resuscitators, approved at a meeting of the Scientific and Practical Council of the Ministry of Health of the Russian Federation (protocol No. 2020 No. 743/12).

The second edition important clarifications have been made in etiology, epidemiology, classification, clinical picture, diagnosis, treatment and prevention of anaphylaxis and clear some definitions for prompt response, and also management of patients with concomitant diseases. Clinical guidelines of anaphylaxis are intended for practitioners of all specialties, students and teachers of medical universities, residents, graduate students.

PDF_2024-2_7-20 (Russian)
HTML_2024-4_7-20_S (Russian)

Full-text of the article is available for this locale: Russian.

References

  1. Sampson H., Muñoz-Furlong A., Campbell R. et al. Second symposium on the definition and management of anaphylaxis: Summary report—Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium. J Allergy Clin Immunol. 2006; 117(2): 391–7. DOI: 10.1016/j.jaci.2005.12.1303
  2. Resuscitation Council UK. Emergency treatment of anaphylaxis: Guidelines for healthcare providers. RCUK, 2021. www.resus.org.uk/library/additional-guidance/guidance-anaphylaxis/emergencytreatment [Accessed on 13 February 2022]
  3. Shaker M., Wallace D., Golden D. et al. Anaphylaxis—a 2020 practice parameter update, systematic review, and Grading of Recommendations, Assessment, Development and Evaluation (GRADE) analysis. J Allergy Clin Immunol. 2020. DOI: 10.1016/j.jaci.2020.01.017
  4. Аллергология. Федеральные клинические рекомендации. Главные редакторы акад. РАН Р.М. Хаитов, проф. Н.И. Ильина. М., 2014. С. 35–47. [Allergology. Federal clinical guidelines. Chief editors acad. RAS R.M. Khaitov, prof. N.I. Ilyina. M., 2014. pp. 35–47 (In Russ)]
  5. Wood R., Camargo C., Lieberman P. et al. Anaphylaxis in America: The prevalence and characteristics of anaphylaxis in the United States. J Allergy Clin Immunol. 2014; 133(2): 461–7. DOI: 10.1016/j.jaci.2013.08.016
  6. Turner P., Gowland M., Sharma V. et al. Increase in anaphylaxis-related hospitalizations but no increase in fatalities: An analysis of United Kingdom national anaphylaxis data, 1992–2012. J Allergy Clin Immunol. 2015; 135(4): 956–63.e1. DOI: 10.1016/j.jaci.2014.10.021
  7. Ye Y., Kim M., Kang H. et al. Predictors of the Severity and Serious Outcomes of Anaphylaxis in Korean Adults: A Multicenter Retrospective Case Study. Allergy Asthma Immunol Res. 2015; 7(1): 22. DOI: 10.4168/aair.2015.7.1.22
  8. Vale S., Smith J., Said M., et al. ASCIA guidelines for prevention of anaphylaxis in schools, pre-schools and childcare: 2012 update. J Paediatr Child Health. 2013; 49(5): 342–5. DOI: 10.1111/jpc.12166
  9. Sole D., Ivancevich J., Borges M. et al. Anaphylaxis in Latin America: a report of the online Latin American survey on anaphylaxis (OLASA). Clinics. 2011; 66(6): 943–7. DOI: 10.1590/s1807-59322011000600004
  10. Ryan K., Martin Caravati E. Life-threatening anaphylaxis following envenomation by two different species of Crotalidae. J Wilderness Med. 1994; 5(3): 263–8. DOI: 10.1580/0953-9859-5.3.263
  11. Fischer D., Vander Leek T., Ellis A., Kim H. Anaphylaxis. Allergy, Asthma & Clinical Immunology. 2018; 14(S2). DOI: 10.1186/s13223-018-0283-4
  12. Panesar S., Javad S., de Silva D. et al. The epidemiology of anaphylaxis in Europe: a systematic review. Allergy. 2013; 68(11): 1353–61. DOI: 10.1111/all.12272
  13. Simons F., Ebisawa M., Sanchez-Borges M. et al. 2015 update of the evidence base: World Allergy Organization anaphylaxis guidelines. World Allergy Organ J. 2015; 8: 32. DOI: 10.1186/s40413-015-0080-1
  14. Есакова Н.В., Пампура А.Н. Пищевая анафилаксия у детей: ретроспективный анализ 53 случаев. Российский Аллергологический Журнал. 2013; 5: 22–7. [Esakova N.V., Pampura A.N. Food anaphylaxis in children: a retrospective analysis of 53 cases. Russian journal of Allergology. 2013; 5: 22–7. (In Russ)]
  15. Bock S., Muñoz-Furlong A., Sampson H. Fatalities due to anaphylactic reactions to foods. J Allergy Clin Immunol. 2001; 107(1): 191–3. DOI: 10.1067/mai.2001.112031
  16. Sampson H., Muñoz-Furlong A., Bock S. et al. Symposium on the Definition and Management of Anaphylaxis: Summary report. J Allergy Clin Immunol. 2005; 115(3): 584–91. DOI: 10.1016/j.jaci.2005.01.009
  17. Simons F. Anaphylaxis. J Allergy Clin Immunol. 2010; 125(2): S161–S181. DOI: 10.1016/j.jaci.2009.12.981
  18. Clinical aspects of Immunology. 3rd edn. Gell P.G.H., Coombs R.R.A., Lachmann R. (eds) Oxford: Blackwell Scientific Publications, 1975.
  19. Сафина Л.Ф., Фассахов Р.С., Решетникова И.Д. и др. Анафилактический шок: ретроспективный анализ госпитализаций по данным аллергологического отделения города Казани. Практическая медицина. 2014; 7(83): 91–5. [Safina L.F., Fassakhov R.S., Reshetnikova I.D., et al. Anaphylactic shock: retrospective analysis of hospitalizations by the data of Kazan allergology department. Practice Medicine. 2014; 7(83): 91–5. (In Russ)]
  20. Ma L., Danoff T., Borish L. Case fatality and population mortality associated with anaphylaxis in the United States. J Allergy Clin Immunol. 2014; 133(4): 1075–83. DOI: 10.1016/j.jaci.2013.10.029
  21. Mehr S., Liew W., Tey D., Tang M. Clinical predictors for biphasic reactions in children presenting with anaphylaxis. Clin Exp Allergy. 2009; 39(9): 1390–6. DOI: 10.1111/j.1365-2222.2009.03276.x
  22. Simons F., Ardusso L., Bilò M. et al. World Allergy Organization Guidelines for the Assessment and Management of Anaphylaxis. World Allergy Organ J. 2011; 4(2): 13–37. DOI: 10.1097/wox.0b013e318211496c
  23. Lieberman P., Nicklas R., Oppenheimer J. et al. The diagnosis and management of anaphylaxis practice parameter: 2010 Update. J Allergy Clin Immunol. 2010; 126(3): 477–80.e42. DOI: 10.1016/j.jaci.2010.06.022
  24. Лопатин А.С. Лекарственный анафилактический шок. М.: Медицина, 1983. [Lopatin A.S. Drug-induced anaphylactic shock. M.: Medicine, 1983. (In Russ)]
  25. de Silva I., Mehr S., Tey D., Tang M. Paediatric anaphylaxis: a 5year retrospective review. Allergy. 2008; 63(8): 1071–6. DOI: 10.1111/j.1398-9995.2008.01719.x
  26. Pumphrey R.S.H. Lessons for management of anaphylaxis from a study of fatal reactions. Clin Exp Allergy. 2000; 30: 1144–50.
  27. Cox L., Larenas-Linnemann D., Lockey R., Passalacqua G. Speaking the same language: The World Allergy Organization Subcutaneous Immunotherapy Systemic Reaction Grading System. J Allergy Clin Immunol. 2010; 125(3): 569–74.e7. DOI: 10.1016/j.jaci.2009.10.060
  28. Simons F. Anaphylaxis in infants: Can recognition and management be improved? J Allergy Clin Immunol. 2007; 120(3): 537–40. DOI: 10.1016/j.jaci.2007.06.025
  29. Worm M., Edenharter G., Ruëff F. et al. Symptom profile and risk factors of anaphylaxis in Central Europe. Allergy. 2012; 67(5): 691–8. DOI: 10.1111/j.1398-9995.2012.02795.x
  30. Muraro A., Roberts G., Worm M. et al. Anaphylaxis: guidelines from the European Academy of Allergy and Clinical Immunology. Allergy. 2014; 69(8): 1026–45. DOI: 10.1111/all.12437
  31. Valent P., Akin C., Arock M. et al. Definitions, Criteria and Global Classification of Mast Cell Disorders with Special Reference to Mast Cell Activation Syndromes: A Consensus Proposal. Int Arch Allergy Immunol. 2012; 157(3): 215–25. DOI: 10.1159/000328760
  32. Laroche D., Gomis P., Gallimidi E., et al. Diagnostic Value of Histamine and Tryptase Concentrations in Severe Anaphylaxis with Shock or Cardiac Arrest during Anesthesia. Anesthesiology. 2014; 121(2): 272–9. DOI: 10.1097/aln.0000000000000276
  33. Soar J., Pumphrey R., Cant A. et al. Emergency treatment of anaphylactic reactions—Guidelines for healthcare providers. Resuscitation. 2008; 77(2): 157–69. DOI: 10.1016/j.resuscitation.2008.02.001
  34. Brown S., Mullins R., Gold M. 2. Anaphylaxis: diagnosis and management. Med J Aust. 2006; 185(5): 283–9. DOI: 10.5694/j.1326-5377.2006.tb00563.x
  35. Harper N., Dixon T., Dugué P. et al. Suspected Anaphylactic Reactions Associated with Anaesthesia. Anaesthesia. 2009; 64(2): 199–211. DOI: 10.1111/j.1365-2044.2008.05733.x
  36. Simons F., Roberts J., Gu X., Simons K. Epinephrine absorption in children with a history of anaphylaxis. J Allergy Clin Immunol. 1998; 101(1): 33–7. DOI: 10.1016/s0091-6749(98)70190-3
  37. Simons F., Gu X., Simons K. Epinephrine absorption in adults: Intramuscular versus subcutaneous injection. J Allergy Clin Immunol. 2001; 108(5): 871–3. DOI: 10.1067/mai.2001.119409
  38. Sampson H., Mendelson L., Rosen J. Fatal and Near-Fatal Anaphylactic Reactions to Food in Children and Adolescents. N Engl J Med. 1992; 327(6): 380–4. DOI: 10.1056/nejm199208063270603
  39. Söreide E., Buxrud T., Harboe S. Severe anaphylactic reactions outside hospital: etiology, symptoms and treatment. Acta Anaesthesiol Scand. 1988; 32(4): 339–42. DOI: 10.1111/j.1399-6576.1988.tb02740.x
  40. Turner P.J., Soar J., Dodd A., et al. Emergency treatment of anaphylaxis. Guidelines for healthcare providers. Working Group of Resuscitation Council UK. May 2021.
  41. Незабудкин С.Н., Галустян А.Н., Незабудкина А.С. и др. Анафилактический шок. Современный взгляд. Медицина: теория и практика. 2020; 3(4): 143–50. [Nezabudkin S.N., Galustyan A.N., Nezabudkin A.S., et al. Anaphylactic shock. Modern point of view. Medicine: theory and practice. 2020; 3(4): 143–50. (In Russ)]
  42. Sheikh A. et al. Adrenaline for the treatment of anaphylaxis: Cochrane systematic review. Allergy. 2009; 64(2): 204–12.
  43. Campbell R.L. et al. Epinephrine in anaphylaxis: higher risk of cardiovascular complications and overdose after administration of intravenous bolus epinephrine compared with intramuscular epinephrine. J Allergy Clin Immunol Pract. 2015; 3(1): 76–80.
  44. McLean-Tooke A., Bethune C., Fay A., Spickett G. Adrenaline in the treatment of anaphylaxis: what is the evidence? BMJ. 2003; 327(7427): 1332–5. DOI: 10.1136/bmj.327.7427.1332
  45. Anaphylaxis: Emergency treatment guidelines, 2017 (https://allergy.org.au/)
  46. Pumphrey R., Gowland M. Further fatal allergic reactions to food in the United Kingdom, 1999–2006. J Allergy Clin Immunol. 2007; 119(4): 1018–9. DOI: 10.1016/j.jaci.2007.01.021
  47. Аллергология. Фармакотерапия ошибок. Руководство для врачей. Под редакцией акад. РАН и РАМН Р.М. Хаитова. 2013. [Allergology. Pharmacotherapy of errors. Guide for doctors. Edited by Academician RAS and RAMS R.M. Khaitov, 2013. (In Russ)]
  48. Li Х., Ma Q., Yin J., et al. A Clinical Practice Guidelines for the Emergency Management of Anaphylaxis. Frontiers in Pharmacology. 2022; 13: 1–22. DOI: 10.3389/fphar.2022.845689
  49. Kolawole H., Marshall S., Crilly H., et al. Australian and New Zealand Anaesthetic Allergy Group/ Australian and New Zealand College of Anaesthetists Perioperative Anaphylaxis Management Guidelines. Anaesth Intensive Care. 2017; 45(2): 151–8.
  50. Тактика диагностики и лечения аллергических заболеваний и иммунодефицитов. Практическое руководство. Под ред. акад. РАН Р.М. Хаитова. М.: ГЭОТАР-Медиа, 2019. С. 90–5. [Tactics for diagnosis and treatment of allergic diseases and immunodeficiencies. Practical guide. Edited by Academician of the Russian Academy of Sciences R.M. Khaitov. M.: GEOTAR-Media, 2019. P. 90–5. (In Russ)]
  51. Аллергология и клиническая иммунология. Клинические рекомендации. Главные редакторы акад. РАН Р.М. Хаитов, проф. Н.И. Ильина. М., 2019. С. 52–69. [Allergology and clinical immunology. Clinical recommendations. Chief editors acad. RAS R.M. Khaitov, prof. N.I. Ilyina. M., 2019. pp. 52–69. (In Russ)]
  52. Dykewicz M., Fineman S. Executive Summary of Joint Task Force Practice Parameters on Diagnosis and Management of Rhinitis. Ann Allergy Asthma Immunol. 1998; 81(5): 463–8. DOI: 10.1016/s1081-1206(10)63152-3
  53. Баялиева А.Ж., Заболотских И.Б., Лебединский К.М. и др. Профилактика и лечение периоперационной анафилаксии и анафилактического шока. Анестезиология и реаниматология. 2018; 1: 82–90. DOI: 10.17116/anaesthesiology201801-02182 [Bayalieva A.Zh., Zabolotskikh I.B., Lebedinskii K.M., et al. Prevention and treatment of perioperative anaphylaxis and anaphylactic shock. Russian Journal of Anesthesiology and Reanimatology. 2018; 1: 82–90. DOI: 10.17116/anaesthesiology201801-02182 (In Russ)]
  54. Dribin T.E., Motosue M.S., Campbell R.L. Overview of Allergy and Anaphylaxis. Emerg Med Clin North Am. 2022; 40(1): 1–17.
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Copyright (c) 2024 Annals of Critical Care